前收市價 | 2.4500 |
開市 | 2.4500 |
買盤 | 1.4500 |
賣出價 | 2.2000 |
拍板 | 5.00 |
到期日 | 2025-01-17 |
今日波幅 | 2.4500 - 2.4500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 7 |
Merck's (MRK) vaccine, Capvaxive, gets unanimous recommendation by a CDC committee for adults aged 65 years and older for pneumococcal vaccination and those with certain other underlying conditions.
CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.
ImmunityBio (IBRX) rises 17% in the past week as it announces insurance coverage as well as the treatment of the first patients with its newly approved bladder cancer immunotherapy, Anktiva.